Skip to main content
SpringerLink
Log in

CAR-T-Zell-Therapie

Auch beim multiplen Myelom eine Option?

  • Allgemeine Onkologie
  • Wie wirkt was... ?
  • Published:
Im Fokus Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

© Debbie Maizels/Springer Nature, Majzner et al. Nat Med. 2019;25(9):1341-55

Abb. 2

© modifiziert nach Debbie Maizels/Springer Nature, Majzner RG et al. Nat Med. 2019;25(9):1341-55

Author information

Authors and Affiliations

  1. freie Journalistin, Dresden, Germany

    Sabrina Kempe

  2. Med. Klinik, Inn. Medizin V Univ. Klinikum Heidelberg u. NCT, Im Neuenheimer Feld 672, 69120, Heidelberg, Germany

    Hartmut Goldschmidt

Authors
  1. Sabrina Kempe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hartmut Goldschmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sabrina Kempe.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kempe, S., Goldschmidt, H. Auch beim multiplen Myelom eine Option?. Im Fokus Onkologie 23, 59–62 (2020). https://doi.org/10.1007/s15015-020-2326-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15015-020-2326-1

Search

Navigation